The invention relates to a traditional Chinese medicine for treating the chronic pulmonary heart disease. The traditional Chinese medicine comprises the following raw materials, by weight, 10-15 parts of ginseng, 10-15 parts of Radix Ophiopogonis, 10-15 parts of Chinese magnoliavine, 10-15 parts of Rhizoma Atractylodis Macrocephalae, 10-15 parts of Sappanwood, 5-8 parts of Cassia Twig, 10-15 parts of Radix Astragali, 10-15 parts of Salvia miltiorrhiza, 10-15 parts of salted aconite root, 8-12 parts of Tokay Gecko, 10-15 parts of epimeddium, 10-15 parts of Chinese yam, 10-15 parts of bitter apricot kernel, 10-15 parts of Malaytea Scurfpea Fruit, 10-15 parts of Pepperweed Seed, 10-15 parts of Stemona sessilifolia, 10-15 parts of Poria cocos, 10-15 parts of peach kernel, 10-15 parts of Common Coltsfoot Flower, 5-8 parts of fried licorice, 10-15 parts of lumbricus and 10-15 parts of Herba Houttuyniae. The traditional Chinese medicine for treating the chronic pulmonary heart disease of theinvention has the advantages of simple preparation method, easily controlled quality, high cure rate, difficult recurrence, and no toxic side effect.